SSII
SS Innovations International, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$2.35
−1.26%Oct 26, 2026, 12:30 UTC
SS Innovations International announced that its SSi Mantra surgical robotic system and SSi MantrAsana tele-surgeon console were showcased in telesurgeries at October 2026 conferences in Barcelona and New Delhi.
Source:Oct 13, 2026, 12:30 UTC
SS Innovations International submitted a response to the FDA’s request for additional information regarding its 510(k) submission for the SSi Mantra surgical robotic system.
Source:Oct 13, 2026, 10:19 UTC
SS Innovations International, Inc. issued Growth Capital Partners LLP a secured convertible promissory note with an original principal amount of $21,025,000 for an aggregate purchase price of $20,000,000.
Aug 26, 2026, 00:00 UTC
Sarah Romano departed as Chief Financial Officer of SS Innovations International, Inc. on August 21, 2026.
Aug 23, 2026, 12:30 UTC
Kings Hospital launched its robotic surgery programme using India's SSI Mantra Surgical Robotic System, with the first robot-assisted cholecystectomy performed in Sri Lanka.
Source:Aug 13, 2026, 12:30 UTC
SS Innovations reported its second quarter 2026 financial results, with record quarterly revenue driven by strong growth in SSi Mantra unit sales.
Source:Jul 14, 2026, 00:00 UTC
SS Innovations International, Inc. appointed Sarah M. Romano as Chief Financial Officer, effective August 3, 2026.
Jun 18, 2026, 00:00 UTC
SS Innovations International, Inc. entered into an ATM Sales Agreement with Virtu Americas LLC to sell up to $50 million of its common stock from time to time.
Jun 4, 2026, 12:30 UTC
SS Innovations International completed the world's longest-distance robotic telesurgery using its SSi Mantra system between Guyana and India.
Source: